君实生物-U
(688180)
| 流通市值：255.44亿 | | | 总市值：342.20亿 |
| 流通股本：7.66亿 | | | 总股本：10.27亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,696,210,935.65 | 726,287,839.6 | 2,498,420,333.97 | 1,805,880,133.52 |
| 营业总成本 | 1,788,098,231.24 | 861,878,028.11 | 3,444,363,178.98 | 2,473,163,074.83 |
| 其他经营收益 | | | | |
| 营业利润 | -19,012,392.22 | -28,587,860.48 | -999,463,383.92 | -671,058,241.61 |
| 利润总额 | -33,380,161.74 | -37,842,584.71 | -1,023,274,342.07 | -692,393,121.41 |
| 净利润 | -40,823,699.21 | -43,425,421.84 | -1,009,393,410.45 | -674,309,869.11 |
| 每股收益 | | | | |
| 其他综合收益 | 1,991,646.97 | 5,922,552.06 | -6,750,254.67 | -146,608.69 |
| 综合收益总额 | -38,832,052.24 | -37,502,869.78 | -1,016,143,665.12 | -674,456,477.8 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,205,245,445.33 | 5,874,389,312.73 | 4,457,703,511.07 | 4,445,064,264.39 |
| 非流动资产: | | | | |
| 非流动资产合计 | 8,996,318,247.02 | 8,277,609,988.83 | 7,924,623,384.29 | 7,242,977,370.96 |
| 资产总计 | 14,201,563,692.35 | 14,151,999,301.56 | 12,382,326,895.36 | 11,688,041,635.35 |
| 流动负债: | | | | |
| 流动负债合计 | 2,891,153,672.8 | 2,746,265,120.57 | 2,778,278,033.83 | 2,748,630,846.13 |
| 非流动负债: | | | | |
| 非流动负债合计 | 5,158,946,342.74 | 5,315,626,038.83 | 3,547,454,580.76 | 2,644,091,377.34 |
| 负债合计 | 8,050,100,015.54 | 8,061,891,159.4 | 6,325,732,614.59 | 5,392,722,223.47 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,943,737,286.52 | 5,896,037,652.78 | 6,030,434,432.07 | 6,216,157,386.49 |
| 股东权益合计 | 6,151,463,676.81 | 6,090,108,142.16 | 6,056,594,280.77 | 6,295,319,411.88 |
| 负债和股东权益合计 | 14,201,563,692.35 | 14,151,999,301.56 | 12,382,326,895.36 | 11,688,041,635.35 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,647,575,578.25 | 841,165,588.93 | 2,841,283,482.04 | 2,139,612,068.29 |
| 经营活动现金流出小计 | 1,716,137,799.12 | 783,316,353.94 | 3,360,851,214.36 | 2,483,022,336.46 |
| 经营活动产生的现金流量净额 | -68,562,220.87 | 57,849,234.99 | -519,567,732.32 | -343,410,268.17 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,086,881,874.83 | 660,942,551.93 | 2,325,262,549.2 | 1,718,649,206.7 |
| 投资活动现金流出小计 | 3,525,247,294.15 | 1,202,307,578.74 | 3,905,973,432.42 | 2,627,438,852.34 |
| 投资活动产生的现金流量净额 | -1,438,365,419.32 | -541,365,026.81 | -1,580,710,883.22 | -908,789,645.64 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,544,089,533.49 | 2,421,047,188.74 | 4,764,723,517.2 | 3,533,008,134.16 |
| 筹资活动现金流出小计 | 899,676,067.44 | 628,698,526.33 | 2,535,417,774.79 | 1,990,436,816.3 |
| 筹资活动产生的现金流量净额 | 1,644,413,466.05 | 1,792,348,662.41 | 2,229,305,742.41 | 1,542,571,317.86 |
| 汇率变动对现金及现金等价物的影响 | -25,542,687.74 | -12,144,143 | -21,706,525.95 | -7,377,820.48 |
| 现金及现金等价物净增加额 | 111,943,138.12 | 1,296,688,727.59 | 107,320,600.92 | 282,993,583.57 |
| 期末现金及现金等价物余额 | 2,705,942,847.86 | 3,890,688,437.33 | 2,593,999,709.74 | 2,769,672,692.39 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 111,943,138.12 | - | 107,320,600.92 | - |
最新报告期：2026-09-10| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中邮证券 | 盛丽华 | -0.37 | 0.11 | 0.54 | 2026-09-10 |
| 方正证券 | 许睿 | -0.40 | 0.05 | 0.41 | 2026-08-28 |
| 浙商证券 | 郭双喜 | -0.33 | 0.05 | 0.43 | 2026-07-21 |